These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2083972)

  • 1. Drug-induced fever: a clinical report and challenge test with calcium dobesilate.
    Puyana J; Fraj J; De La Hoz F; Davila I; Vergara C; Cuesta J
    Int Arch Allergy Appl Immunol; 1990; 92(4):364-5. PubMed ID: 2083972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug fever attributable to Calcium Dobesilate.
    Galindo Bonilla PA; García Rodríguez R; Feo Brito F; Encinas Barrios C; G-omez Torrijos E; Fernández Martínez F
    Allergol Immunopathol (Madr); 1996; 24(1):19-21. PubMed ID: 8882756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent agranulocytosis after taking calcium dobesilate].
    Kulessa W; Becker EW; Berg PA
    Dtsch Med Wochenschr; 1992 Mar; 117(10):372-4. PubMed ID: 1544335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium dobesilate-induced hyperpyrexia: A case report.
    Yang H; Yuan HL; Zhang ZP; Zhang HK; Liu MW
    Medicine (Baltimore); 2023 Oct; 102(43):e35785. PubMed ID: 37904360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium dobesilate-induced agranulocytosis.
    García Benayas E; García Díaz B; Pérez G
    Pharm World Sci; 1997 Oct; 19(5):251-2. PubMed ID: 9368927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
    Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
    Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches.
    Ibáñez L; Ballarín E; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):763-7. PubMed ID: 11214789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
    Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
    Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of drug-induced agranulocytosis: the case of calcium dobesilate.
    Zapater P; Horga JF; García A
    Eur J Clin Pharmacol; 2003 Mar; 58(11):767-72. PubMed ID: 12634984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium dobesilate: pharmacology and future approaches.
    Tejerina T; Ruiz E
    Gen Pharmacol; 1998 Sep; 31(3):357-60. PubMed ID: 9703201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced fever due to diltiazem.
    Dominguez EA; Hamill RJ
    Arch Intern Med; 1991 Sep; 151(9):1869-70. PubMed ID: 1888256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
    Zapater Hernández P; Horga de la Parte JF; García AG
    An Med Interna; 2002 Jun; 19(6):275-82. PubMed ID: 12152385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency.
    Rabe E; Ballarini S; Lehr L;
    Phlebology; 2016 May; 31(4):264-74. PubMed ID: 25991692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium dobesilate in the treatment of primary venous insufficiency of the lower limbs. A controlled clinical study].
    Pecchi S; De Franco V; Damiani P; Guerrini M; Di Perri T
    Clin Ter; 1990 Mar; 132(6):409-17. PubMed ID: 2139387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid hypersensitivity and fever: a case report.
    Sesin GP; Kirschenbaum H
    Am J Hosp Pharm; 1979 Nov; 36(11):1565-7. PubMed ID: 517548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial.
    Schram MT; Stam F; de Jongh RT; de Vries G; van Dijk RA; Serné EH; Lampe D; Nanayakkara PW; Tushuizen ME; Scheffer PG; Schalkwijk CG; Kamper AM; Stehouwer CD
    Atherosclerosis; 2003 Sep; 170(1):59-72. PubMed ID: 12957683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium dobesilate-induced agranulocytosis.
    Duggal L; Thukral R; Kumar S
    J Assoc Physicians India; 2005 Apr; 53():320-1. PubMed ID: 15987021
    [No Abstract]   [Full Text] [Related]  

  • 18. [Agranulocytosis induced by calcium dobesilate].
    Cladera Serra A; Blasco Mascaró I; Oliva Berini E; Ramos Díaz F
    Med Clin (Barc); 1995 Oct; 105(14):558-9. PubMed ID: 8523936
    [No Abstract]   [Full Text] [Related]  

  • 19. Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat.
    Brunet J; Farine JC; Garay RP; Hannaert P
    Eur J Pharmacol; 1998 Oct; 358(3):213-20. PubMed ID: 9822887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium dobesilate: neutropenia.
    Prescrire Int; 2010 Oct; 19(109):218. PubMed ID: 21188809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.